NYSE:ENZ - Enzo Biochem News Headlines

Sign in or create an account to add this stock to your watchlist.
$2.99 +0.04 (+1.36 %)
(As of 12/12/2018 04:00 PM ET)
Previous Close$2.95
Today's Range$2.95 - $3.03
52-Week Range$2.92 - $8.95
Volume234,000 shs
Average Volume163,913 shs
Market Capitalization$152.40 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32

Headlines

Enzo Biochem (NYSE ENZ) News Headlines

Source:
DateHeadline
Enzo Biochem, Inc. (ENZ) Q1 2019 Results - Earnings Call TranscriptEnzo Biochem, Inc. (ENZ) Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - December 11 at 4:36 PM
Enzo Biochem FQ1 top line down 21%Enzo Biochem FQ1 top line down 21%
seekingalpha.com - December 11 at 10:39 AM
Enzo Biochem misses by $0.02, beats on revenueEnzo Biochem misses by $0.02, beats on revenue
seekingalpha.com - December 11 at 10:39 AM
Enzo Biochem: Fiscal 1Q Earnings SnapshotEnzo Biochem: Fiscal 1Q Earnings Snapshot
finance.yahoo.com - December 11 at 10:39 AM
Enzo Biochem (ENZ) Issues  Earnings Results, Misses Expectations By $0.02 EPSEnzo Biochem (ENZ) Issues Earnings Results, Misses Expectations By $0.02 EPS
www.americanbankingnews.com - December 11 at 8:07 AM
Earnings Scheduled For December 10, 2018 - BenzingaEarnings Scheduled For December 10, 2018 - Benzinga
www.benzinga.com - December 10 at 4:22 PM
Enzo Biochem Reports Fiscal 2019 First Quarter ResultsEnzo Biochem Reports Fiscal 2019 First Quarter Results
finance.yahoo.com - December 10 at 4:22 PM
Enzo Biochem gets $2.8 million tax deal for expansion from Babylon IDAEnzo Biochem gets $2.8 million tax deal for expansion from Babylon IDA
www.msn.com - December 9 at 9:28 AM
Enzo Biochem Schedules Teleconference to Discuss First Quarter 2019 Results Tuesday, December 11, 2018 at 8:30 AM E.T. - Business WireEnzo Biochem Schedules Teleconference to Discuss First Quarter 2019 Results Tuesday, December 11, 2018 at 8:30 AM E.T. - Business Wire
www.businesswire.com - December 8 at 9:33 AM
Enzo Biochem (ENZ) Scheduled to Post Earnings on MondayEnzo Biochem (ENZ) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - December 8 at 9:22 AM
Enzo Biochem Schedules Teleconference to Discuss First Quarter 2019 Results Tuesday, December 11, 2018 at 8:30 AM E.T.Enzo Biochem Schedules Teleconference to Discuss First Quarter 2019 Results Tuesday, December 11, 2018 at 8:30 AM E.T.
www.businesswire.com - December 6 at 9:41 AM
Enzo Biochem Reports Publication of Study on Therapeutic Candidate SK1-I Detailing Promising Results in a Model of Treatment-Resistant Breast CancerEnzo Biochem Reports Publication of Study on Therapeutic Candidate SK1-I Detailing Promising Results in a Model of Treatment-Resistant Breast Cancer
finance.yahoo.com - December 3 at 9:55 AM
What Kind Of Shareholder Owns Most Enzo Biochem Inc (NYSE:ENZ) Stock?What Kind Of Shareholder Owns Most Enzo Biochem Inc (NYSE:ENZ) Stock?
finance.yahoo.com - November 14 at 4:13 PM
Enzo Biochem Trades At A Discount To Its Sum Of The Parts Value With Multiple Ways To WinEnzo Biochem Trades At A Discount To Its Sum Of The Parts Value With Multiple Ways To Win
seekingalpha.com - October 22 at 9:42 AM
Edited Transcript of ENZ earnings conference call or presentation 16-Oct-18 12:30pm GMTEdited Transcript of ENZ earnings conference call or presentation 16-Oct-18 12:30pm GMT
finance.yahoo.com - October 17 at 9:39 AM
Enzo Biochem, Inc. (ENZ) Q4 2018 Results - Earnings Call TranscriptEnzo Biochem, Inc. (ENZ) Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - October 16 at 4:02 PM
Enzo Biochem fiscal Q4 revenue down 13%Enzo Biochem fiscal Q4 revenue down 13%
seekingalpha.com - October 16 at 9:35 AM
Enzo Biochem misses by $0.06, misses on revenueEnzo Biochem misses by $0.06, misses on revenue
seekingalpha.com - October 16 at 9:35 AM
Enzo Biochem Reports Fourth Quarter and Fiscal 2018 ResultsEnzo Biochem Reports Fourth Quarter and Fiscal 2018 Results
finance.yahoo.com - October 15 at 4:09 PM
Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal 2018 Results Tuesday, October 16, 2018 at 8:30 AM E.T.Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal 2018 Results Tuesday, October 16, 2018 at 8:30 AM E.T.
finance.yahoo.com - October 11 at 4:01 PM
Enzo Biochem to Acquire New Facility for Manufacturing and Distribution to Advance Its Diagnostic and Therapeutic Growth StrategyEnzo Biochem to Acquire New Facility for Manufacturing and Distribution to Advance Its Diagnostic and Therapeutic Growth Strategy
finance.yahoo.com - August 27 at 10:30 AM
Form 4 ENZO BIOCHEM INC For: Jul 31 Filed by: WEINER BARRY WForm 4 ENZO BIOCHEM INC For: Jul 31 Filed by: WEINER BARRY W
www.streetinsider.com - August 4 at 8:28 AM
Form 4 ENZO BIOCHEM INC For: Jul 31 Filed by: RABBANI ELAZARForm 4 ENZO BIOCHEM INC For: Jul 31 Filed by: RABBANI ELAZAR
www.streetinsider.com - August 4 at 8:28 AM
Enzo Biochem validates three new cancer biomarker testsEnzo Biochem validates three new cancer biomarker tests
seekingalpha.com - July 18 at 3:59 PM
Enzo Biochem Reports Validation of Three High Quality, Low Cost Biomarkers for Detecting Cancers and Their ...Enzo Biochem Reports Validation of Three High Quality, Low Cost Biomarkers for Detecting Cancers and Their ...
www.businesswire.com - July 18 at 9:11 AM
Enzo Biochem Reports Validation of Three High Quality, Low Cost Biomarkers for Detecting Cancers and Their Progression, Especially in Women’s Health AreaEnzo Biochem Reports Validation of Three High Quality, Low Cost Biomarkers for Detecting Cancers and Their Progression, Especially in Women’s Health Area
finance.yahoo.com - July 18 at 9:11 AM
Benzingas Daily Biotech Pulse: FDA Greenlights Tandem Diabetes Insulin Pump, More IPOs On TapBenzinga's Daily Biotech Pulse: FDA Greenlights Tandem Diabetes' Insulin Pump, More IPOs On Tap
www.benzinga.com - June 22 at 11:42 AM
Edited Transcript of ENZ earnings conference call or presentation 12-Jun-18 12:30pm GMTEdited Transcript of ENZ earnings conference call or presentation 12-Jun-18 12:30pm GMT
finance.yahoo.com - June 13 at 9:36 AM
Benzingas Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis CandidateBenzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate
finance.yahoo.com - June 12 at 4:05 PM
Enzo Biochem misses by $0.04, misses on revenueEnzo Biochem misses by $0.04, misses on revenue
seekingalpha.com - June 12 at 9:38 AM
Enzo Biochem FQ3 top line down 6%, lab services down 7%; shares down 1% after hoursEnzo Biochem FQ3 top line down 6%, lab services down 7%; shares down 1% after hours
seekingalpha.com - June 12 at 9:38 AM
Enzo Biochem Reports Third Quarter ResultsEnzo Biochem Reports Third Quarter Results
finance.yahoo.com - June 12 at 9:38 AM
Enzo Biochem: Fiscal 3Q Earnings SnapshotEnzo Biochem: Fiscal 3Q Earnings Snapshot
finance.yahoo.com - June 12 at 9:38 AM
Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2018 Results Tuesday, June 12, 2018 at 8:30 AM E.T.Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2018 Results Tuesday, June 12, 2018 at 8:30 AM E.T.
finance.yahoo.com - June 6 at 4:06 PM
Health Care Sector Update for 04/24/2018: ENZ,HOLX,BIIB,CNC,INCYHealth Care Sector Update for 04/24/2018: ENZ,HOLX,BIIB,CNC,INCY
www.nasdaq.com - April 24 at 4:17 PM
Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement ...Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement ...
www.businesswire.com - April 24 at 4:17 PM
BRIEF-Enzo Biochem Says Patent Trial And Appeal Board Has Denied A Petition Filed By Hologic For Inter Partes ...BRIEF-Enzo Biochem Says Patent Trial And Appeal Board Has Denied A Petition Filed By Hologic For Inter Partes ...
www.reuters.com - April 24 at 4:17 PM
Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement CasePatent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement Case
finance.yahoo.com - April 24 at 4:17 PM
Report: Exploring Fundamental Drivers Behind Enzo Biochem, The Hackett Group, Rexford Industrial Realty, Green ...Report: Exploring Fundamental Drivers Behind Enzo Biochem, The Hackett Group, Rexford Industrial Realty, Green ...
globenewswire.com - April 24 at 9:50 AM
Notable Monday Option Activity: BA, ENZ, WDCNotable Monday Option Activity: BA, ENZ, WDC
www.nasdaq.com - April 24 at 9:50 AM
Edited Transcript of ENZ earnings conference call or presentation 13-Mar-18 12:30pm GMTEdited Transcript of ENZ earnings conference call or presentation 13-Mar-18 12:30pm GMT
finance.yahoo.com - March 18 at 9:50 AM
Enzo Biochem (ENZ) Q2 2018 Results - Earnings Call Transcript - Seeking AlphaEnzo Biochem (ENZ) Q2 2018 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 14 at 11:06 AM
Earnings Outlook For Enzo Biochem - BenzingaEarnings Outlook For Enzo Biochem - Benzinga
www.benzinga.com - March 14 at 11:06 AM
Earnings Outlook For Enzo BiochemEarnings Outlook For Enzo Biochem
finance.yahoo.com - March 13 at 5:54 PM
Enzo Biochem Reports Second Quarter and First Half ResultsEnzo Biochem Reports Second Quarter and First Half Results
finance.yahoo.com - March 12 at 5:03 PM
Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2018 Results Tuesday, March 13, 2018 at 8:30 AM E.T.Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2018 Results Tuesday, March 13, 2018 at 8:30 AM E.T.
finance.yahoo.com - March 8 at 4:47 PM
Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection TestEnzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test
finance.yahoo.com - January 30 at 9:08 AM
Free Post Earnings Research Report: Enzo Biochem’s Revenue Grew 5%; Net Loss NarrowedFree Post Earnings Research Report: Enzo Biochem’s Revenue Grew 5%; Net Loss Narrowed
finance.yahoo.com - January 9 at 9:23 AM
Noteworthy Friday Option Activity: CSX, GLPI, ENZNoteworthy Friday Option Activity: CSX, GLPI, ENZ
www.nasdaq.com - December 15 at 6:04 PM
Blog Exposure - Cancer Genetics Announces Best Diagnostic Modality to Evaluate PD-L1 in Diffuse Large B-Cell LymphomasBlog Exposure - Cancer Genetics Announces Best Diagnostic Modality to Evaluate PD-L1 in Diffuse Large B-Cell Lymphomas
finance.yahoo.com - December 13 at 9:35 AM
This page was last updated on 12/12/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel